dc.contributor.author
Ignatyev, Yuriy
dc.contributor.author
Timm, Juergen
dc.contributor.author
Heinze, Martin
dc.contributor.author
Indefrey, Sonja
dc.contributor.author
von Peter, Sebastian
dc.date.accessioned
2018-06-08T10:22:26Z
dc.date.available
2017-10-17T10:48:52.884Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/20317
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-23620
dc.description.abstract
This pilot study aimed to evaluate and examine an instrument that integrates
relevant aspects of cross-sectoral (in- and outpatients) mental health care,
is simply to use and shows satisfactory psychometric properties. The
development of the scale comprised literature research, held 14 focus groups
and 12 interviews with patients and health care providers, item-pool
generation, content validation by a scientific expert panel, and face
validation by 90 patients. The preliminary scale was tested on 385 patients
across seven German hospitals with cross-sectoral mental health care (CSMHC)
as part of their treatment program. Psychometric properties of the scale were
evaluated using genuine and transformed data scoring. To check reliability and
postdictive validity of the scale, Cronbach’s α coefficient and multivariable
linear regression were used. This development process led to the development
of an 18-item scale called the “Scale for Evaluation of Psychiatric
Integrative and Continuous Care (SEPICC)” with a two-point and five-point
response options. The scale consists of two sections. The first section
assesses the presence or absence of patients’ experiences with various CSMHC’
relevant components such as home treatment, flexibility of treatments’
switching, case management, continuity of care, cross-sectoral therapeutic
groups, and multidisciplinary teams. The second section evaluates the
patients’ opinions about these relevant components. Using raw and transformed
scoring resulted into comparable results. However, data distribution using
transformed scoring showed a smaller deviation from normality. For the overall
scale, the Cronbach’s α coefficient was 0.82. Self-reported experiences with
relevant components of the CSMHC were positively associated with the patients
approval of these components. In conclusion, the new scale provides a good
starting point for further validation. It can be used as a tool to evaluate
CSMHC. Methodologically, using transformed data scoring appeared to be
preferable because of a smaller deviation from normality and a higher
reliability measured by Cronbach’s α.
en
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
Development and Preliminary Validation of the Scale for Evaluation of
Psychiatric Integrative and Continuous Care—Patient’s Version
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.3389/fpsyt.2017.00162
dcterms.bibliographicCitation.url
http://doi.org/10.3389/fpsyt.2017.00162
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000028324
refubium.note.author
Der Artikel wurde in einer reinen Open-Access-Zeitschrift publiziert.
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000008994
dcterms.accessRights.openaire
open access